Conmed (CNMD) Tops Q3 EPS by 6c, Misses on Revenue; offers FY24 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- US stock futures gain as oil pulls back ahead of Fed decision
- Nvidia to commit $3 bln to Meta share offering as part of bigger AI partnership
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $47.68 --0%
Revenue Growth %: -0.5%
Financial Fact:
Interest expense: 3.86M
Today's EPS Names:
OMID, SICP, SCKT, More
Revenue Growth %: -0.5%
Financial Fact:
Interest expense: 3.86M
Today's EPS Names:
OMID, SICP, SCKT, More
Join SI Premium – FREE
Conmed (NYSE: CNMD) reported Q3 EPS of $1.05, $0.06 better than the analyst estimate of $0.99. Revenue for the quarter came in at $316.7 million versus the consensus estimate of $318.15 million.
GUIDANCE:
Conmed sees FY2024 EPS of $4.00-$4.05, versus the consensus of $3.99. Conmed sees FY2024 revenue of $1.3-1.31 billion, versus the consensus of $1.31 billion.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- S&P Global (SPGI) Tops Q3 EPS by 16c
- Applied Industrial Technologies (AIT) Tops Q1 EPS by 9c ; Offers Guidance
- SoFi Technologies (SOFI) Tops Q3 EPS by 1c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
